Pectoris of Coronary Heart Diseases
Conditions
Interventions
1:Qishen Yiqi dropping pill + Fufang Danshen dropping
2:Fufang Danshen dropping pill+Qishen Yiqi dropping pill placebo
Sponsors
Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) Patients aged 40-75 years old; 2) Provision of signed informed consent; 3) Diagnosis of angina pectoris due to coronary heart diseases (stable angina, class I to III); 4) TCM pattern diagnosis of qi deficiency and blood stasis or qi and blood stasis.
Exclusion criteria
Exclusion criteria: 1) Patients below 40 or above 75 years old; 2) Diagnosis of NYHA class IV; 3) Uncontrolled class III hypertension (SP higher than 180mmHg and/or BP higher than 110mmHg); 4) Presence of severe arrhythmia; 5) Patients with serious primary hepatic, renal or hematologic illnesses, and with mental diseases or malignant tumors; 6) Presence of active peptic ulcer and other hemorrhagic diseases; 7) Pregnancy or lactation; 8) Patients with other complications who should not be included in the trial as judged by the recruiting personnel; 9) Patients with an allergic constitution or who has a history of allergy to the investigational drug; 10) Participation in another clinical trial either currently or within the last three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of the clinical symptoms; | — |
Countries
China
Contacts
Public ContactCao Hongbo
Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine
Outcome results
None listed